pantoprazol "sandoz" 20 mg enterotabletter
sandoz a/s - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg
pantoprazol "sandoz" 40 mg enterotabletter
sandoz a/s - pantoprazolnatriumsesquihydrat - enterotabletter - 40 mg
ulprix 20 mg enterotabletter
glenmark arzneimittel gmbh - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg
ulprix 40 mg enterotabletter
glenmark arzneimittel gmbh - pantoprazolnatriumsesquihydrat - enterotabletter - 40 mg
pantoprazol "nordic prime" 20 mg enterotabletter
nordic prime aps - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg
pantoprazol "paranova" 40 mg enterotabletter
paranova danmark a/s - pantoprazolnatriumsesquihydrat - enterotabletter - 40 mg
pantoprazol "kalceks" 40 mg pulver til injektionsvæske, opløsning
kalceks as - pantoprazolnatriumsesquihydrat - pulver til injektionsvæske, opløsning - 40 mg
midazolam "hameln" 5 mg/ml injektions-/infusionsvæske, opløsning
hameln pharma gmbh - midazolamhydrochlorid - injektions-/infusionsvæske, opløsning - 5 mg/ml
lumykras
amgen europe bv - sotorasib - carcinom, ikke-småcellet lunge - antineoplastiske midler - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
midazolam "b. braun" 5 mg/ml injektions-/infusionsvæske, opløsning
b. braun melsungen - midazolam - injektions-/infusionsvæske, opløsning - 5 mg/ml